Location
United States, North America
Cheque size
$10M - $350M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
Medical Devices
About Investor
Dylan Morris is a Managing Director at Insight Partners, focused on investments in computational biology at the intersection of software and life science. Insight states its growth equity funds generally invest $10.0M–$350.0M of equity in a company (Dylan’s individual check size is not publicly broken out). Before Insight, he invested at Innovation Endeavors and was a General Partner at CRV, where he helped build the firm’s bioengineering practice. His earlier background includes founding work (including Integrated Plasmonics) before his investing career.
Previous investments
Superluminal Medicines
120M |2024
Gameto
33M |2024
Profluent Bio
9M |2022
Similar Investors
FF
Faraz Fatemi
United States, North America
$1M - $30M
Seed
,Series A
,AM
Alex Moore
United States, North America
$3M - $30M
Seed
,SN
Scott Nolan
United States, North America
$500K - $150M
Seed
,Series A
,CH
Cat Hernandez
United States, North America
$100K - $10M
Pre Seed
,Seed
,CG
Chian Gong
United States, North America
$250K - $10M
Pre Seed
,Seed
,MH
Matt Huang
United States, North America
$1M - $100M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.